Arrowhead Research | ARWR - Eigenkapital Und Reserven

Aktienkurs
69.91
Täglich Wechseln
-0.22 -0.31%
Monatlich
21.27%
Jährlich
403.31%
Q2 Prognose
72.33




Eigenkapital Und Reserven Veränderung Datum
Agios Pharmaceuticals USD 1.11B 84M 2026-03
Alnylam Pharmaceuticals USD 789.18M 555.28M 2025-12
Anika Therapeutics USD 143.46M 3.34M 2025-12
Arrowhead Research USD 568.42M 102.37M 2025-12
Heron Therapeutics USD 13.28M 1.6M 2025-12
Incyte USD 5.62B 455.37M 2026-03
Ionis Pharmaceuticals USD 491.41M 2.32M 2026-03
Ligand Pharmaceuticals USD 1.02B 67.04M 2025-12
Merck USD 51.85B 2.79B 2025-09
Moderna USD 8.65B 680M 2025-12
Nektar Therapeutics USD 89.83M 4.75M 2025-12
Novartis USD 46.13B 1.38B 2025-12
Sarepta Therapeutics USD 1.14B 179.5M 2025-12
TG Therapeutics USD 648.02M 40.8M 2025-12
Ultragenyx Pharmaceutical USD 9.16M 142.13M 2025-09
Vertex Pharmaceuticals USD 18.67B 1.35B 2025-12
Xencor USD 635.59M 10.27M 2025-12